Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1288
| Despition | C9orf72 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
| ACPP-1088 | Synthetic Exosome Human CD24 Protein (AC1088) | 50 µg | inquiry |
| ACPP-1598 | Rat SIRPA Protein (AC1598) | 2 µg | inquiry |
| ACPP-1519 | Human MANF Protein (AC1519) | 5 µg | inquiry |
| ACPP-1810 | Rat LIF Protein (AC1810) | 2 µg | inquiry |
| ACPP-1158 | Synthetic Nanodisc Human MC4-R Protein (AC1158) | 10 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1064 | Recombinant Human LSAMP Protein (Fc Tag) (AC1064) | 50 µg | inquiry |
| ACPP-1468 | Human MEIS3 Protein (AC1468) | 5 µg | inquiry |
| ACPP-1095 | Synthetic Nanodisc Human MLC1 Protein (AC1095) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.